Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Chemist stitches up speedier chemical reactions

This is Warren Piers, namesake of the Piers catalyst, in his laboratory at the University of Calgary. Credit: Meghan Sired, University of Calgary
This is Warren Piers, namesake of the Piers catalyst, in his laboratory at the University of Calgary. Credit: Meghan Sired, University of Calgary

Abstract:
New details about the Piers catalyst will help chemical industry improve products

Chemist stitches up speedier chemical reactions

Calgary | Posted on May 11th, 2010

Some people have streets named after them. Warren Piers, a chemistry professor at the University of Calgary, has a catalyst penned after him.

And in a paper published today in the online edition of Nature Chemistry, Piers and former graduate student Edwin van der Eide reveal the inner workings of the Piers catalyst at a molecular level of detail not previously available.

"These details are critical for the development of improved catalysts," says Piers, the paper's co-author and S. Robert Blair Professor of chemistry at the University of Calgary. "It will help us and others find new applications and improved reaction conditions for these catalysts."

A chemical catalyst is a molecule that speeds up a chemical reaction without being consumed in the reaction. Enzymes are nature's catalysts, but humankind has invented catalysts that improve and are often required to drive many commercially important chemical reactions.

Catalysts are so versatile that they are used in many chemical industries, ranging from commodity chemicals, those produced on a large scale, to fine chemicals, specialty products like pharmaceuticals, for example.

Catalysts allow companies to make products more economically (lower energy costs) and more selectively (less waste). The details revealed in this paper open the door to new products and materials, creating new companies and markets. One new application involves the production of biofuel hydrocarbon products from seed oils derived from plants.

The paper explores at a level of detail not seen before the inner workings of a chemical reaction called "olefin metathesis." If knitting a wool sweater, catalysts can be thought of as the knitting needles, while the particular stitches required to fashion the wool into a pattern can be viewed as the chemical reaction.

"When we apply this to chemistry, you could say that the stitches -olefin metathesis reactions- have been around for some time. Chemists have been working for decades to figure out which needles do the work most efficiently," says Piers, whose discovery of more efficient olefin metathesis catalysts is now connected with his name.

"The results of this paper are valuable because we now know important details about a significant reaction," he explains. "The olefin metathesis reaction provides an extremely versatile method to break and reform carbon-carbon bonds in materials used in the manufacture of chemical products."

Materia Inc., a Pasadena-based chemical technology company, has the first rights to further develop and commercialize Piers' technology, which is licensed through UTI. Materia was keen to add Piers' technology to their library of catalysts to make their portfolio more versatile.

The Piers catalyst is related to the Nobel Prize-winning family of catalysts known as the Grubbs catalyst, named for their discoverer Robert Grubbs of Caltech. The Piers system has unique chemical attributes that Materia is hoping to exploit in new applications. While not yet as widely used as the Grubbs catalyst, there is strong growth potential for the Piers catalyst due to its high reactivity.

Mechanistic insights into the ruthenium-catalysed diene ring-closing metathesis reaction by Edwin F. van der Eide and Warren E. Piers is published in Nature Chemistry at www.nature.com/nchem/index.html

####

For more information, please click here

Contacts:
Leanne Yohemas

403-220-5144

Copyright © Eurekalert

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chemistry

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Academic/Education

Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

National Space Society Helps Fund Expanding Frontier’s Brownsville Summer Entrepreneur Academy: National Space Society and Club for the Future to Support Youth Development Program in South Texas June 24th, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project